Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Other Accumulated Expenses (2020 - 2025)

Bio-Techne (TECH) has 6 years of Other Accumulated Expenses data on record, last reported at $1.6 million in Q4 2025.

  • For Q4 2025, Other Accumulated Expenses fell 40.05% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $1.6 million, down 40.05%, while the annual FY2025 figure was $1.6 million, 23.52% down from the prior year.
  • Other Accumulated Expenses reached $1.6 million in Q4 2025 per TECH's latest filing, down from $4.5 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $5.5 million in Q4 2021 and bottomed at $865000.0 in Q1 2023.
  • Average Other Accumulated Expenses over 5 years is $2.8 million, with a median of $2.6 million recorded in 2021.
  • Peak YoY movement for Other Accumulated Expenses: crashed 75.87% in 2022, then skyrocketed 240.92% in 2024.
  • A 5-year view of Other Accumulated Expenses shows it stood at $5.5 million in 2021, then plummeted by 75.87% to $1.3 million in 2022, then soared by 220.32% to $4.2 million in 2023, then tumbled by 37.7% to $2.6 million in 2024, then crashed by 40.05% to $1.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $1.6 million in Q4 2025, $4.5 million in Q3 2025, and $1.6 million in Q2 2025.